Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Mankind Pharma Limited

Mankind Pharma is an Indian pharmaceutical company incorporated in 1995. It is the self-described 4th largest pharmaceutical company in India by domestic sales, focusing on producing pharmaceutical products.

Mankind Pharma

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries.

Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products.

Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients.

Mankind strongly believes and follows its Core Values:

𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External
𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products
𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements
𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone
𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities
𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

MANKIND PHARMA LTD

A tribute to the compassionate heroes who choose to give the gift of life to those in need. #MankindPharma believes that choosing to be an organ donor is an act of spreading kindness. With only 0.86 donors per million, alarmingly low number of registered donors in our country, we urge you to spark a wave of change and choose to be an organ donor today.

Share this video to spread awareness!

#WorldOrganDonationDay #OrganDonation #SpreadingKindness #ServingLife #HealthIsWealth #Mankind #Healthcare #Pharma #Pharmaceutical #Health

Mankind Pharma is pleased to announce its steady performance for this quarter, reflecting our unwavering commitment to innovative healthcare solutions. The company remains focused on expanding to chronic therapies and entering high entry barrier segments with the acquisition of Bharat Serums and Vaccines Limited, to ensure sustained growth and industry leadership.

#MankindPharma #ServingLife

Rajeev Juneja  VC and Managing Director MANKIND PHARMA LTD  In conversation with CNBC-TV18  

BSV’s acquisition marks a pivotal milestone in Mankind’s journey. This strategic partnership solidifies our position as the #1 leader in Gynecology and propels us into a leadership role in women's health and fertility. 

BSV's established Specialty R&D Tech Platforms with complex portfolio across Women’s health, Fertility, critical care and Immunoglobulin segment perfectly aligns with Mankind Pharma's strategic vision to expand its footprint in high entry barrier portfolio.

By combining our strengths, we're creating a formidable force dedicated to delivering innovative solutions and improving the lives of millions.

#MankindPharma #BSVAcquisition #WomensHealth #Fertility #Healthcare #Leadership #Innovation

Watch now:

https://lnkd.in/g85RkxBr

https://lnkd.in/g52ahdYF

For an infection with no known cure,  let’s vow this #WorldHepatitisDay to spread awareness and lower our chances of the deadly infection.

#MankindPharma #ServingLife #SpreadingKindness #HealthIsWealth #Mankind #Healthcare #Pharma #Pharmaceutical #Health

#Budget2024 aligns with #ViksitBharat vision for healthcare. We welcome the focus on medical education, prevention & infrastructure, the allocation for long-term R&D financing for pharma, the bio-manufacturing scheme, and the customs duty exemption for cancer drugs. Overall, a promising direction for a more resilient & accessible healthcare system in India: Mr Arjun Juneja, Chair, FICCI Pharma Committee and COO, MANKIND PHARMA LTD.

#BudgetWithFICCI

In Monsoon, your high fever could be dengue! Skip the guesswork. Stay a step ahead with Rapid News Dengue Home Detection Kit – because hashtag
#MonsoonNahiYeDengueSeasonHai

Buy from your nearest chemist, Apollo Pharmacy, Frank Ross, Amazon, Flipkart & Tata 1 mg. 

#dengue #monsoon #test #detection #testkit #denguekit #season #rain #rapidnewskit #MankindPharma #SevingLife

Metric
Company Name	Mankind Pharma Limited
Symbol	MANKIND
MSH ID	COM:MANKINDPHARMA
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Country	IN
Stage
Employee Count	18.47K
Website	mankindpharma.com
LinkedIn	mankind-pharma-ltd
Founders

Metric
Market Cap	10.01B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	1.22B
Revenue (LTM)
Revenue (NTM)
Gross Profit	841.20M
EBITDA	334.25M
Operating Income	287.23M
Net Income	225.84M
EPS	0.56
Diluted EPS	0.56
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.69
Operating Profit Margin	0.24
EBITDA Margin	0.27
Net Profit Margin	0.19
Return on Equity	0.44
Return on Assets	0.16
Return on Capital Employed	0.25

MANK

COM:MANKINDPHARMA

Mankind Pharma

Last Close

2,551.60

25/11 09:40

Market Cap

848.24B

Beta: -

Volume Today

358.29K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	64.78
P/B Ratio	9.78
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	10.51
EV Multiple	38.82

Metric
Days Sales Outstanding	52.53
Days Payables Outstanding	172.24
Days Inventory Outstanding	176.66
Operating Cycle	206.81
Cash Conversion Cycle	81.38
Asset Turnover	0.89

Metric
Operating Cash Flow	254.12M
Free Cash Flow	208.98M
Cash Flow to Debt	5.17
Operating Cash Flow/Sales	0.11
Free Cash Flow Yield	0.00

Metric
Cash & Equivalents	45.10M
Accounts Receivable	-34.23M
Inventory	183.40M
Goodwill	2.36M
Debt to Capitalization	0.02
Debt to Assets	0.02
Current Ratio	2.66
Quick Ratio	2.37

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue